Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer

Clinical trial NCT01273402 · WITHDRAWN

Trial details

NCT number: NCT01273402
Sponsor: Gilead Sciences
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2011-02-01
Primary completion: 2013-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.